Monden N - Search Results

1

Curative resection of gastric cancer: limitation of peritoneal lavage cytology in predicting the outcome.

Abe S, Yoshimura H, Tabara H, Tachibana M, Monden N, Nakamura T, Nagaoka S. Abe S, et al. Among authors: monden n. J Surg Oncol. 1995 Aug;59(4):226-9. doi: 10.1002/jso.2930590405. J Surg Oncol. 1995. PMID: 7630168

2

Long-term results of operation for carcinoma of the stomach in T1/T2 stages: critical evaluation of the concept of early carcinoma of the stomach.

Abe S, Yoshimura H, Nagaoka S, Monden N, Kinugasa S, Nagasue N, Nakamura T. Abe S, et al. Among authors: monden n. J Am Coll Surg. 1995 Nov;181(5):389-96. J Am Coll Surg. 1995. PMID: 7582205

3

Prognostic significance of proliferating cell nuclear antigen (PCNA) in squamous cell carcinoma of the esophagus.

Kinugasa S, Tachibana M, Hishikawa Y, Abe S, Yoshimura H, Monden N, Dhar DK, Nagasue N. Kinugasa S, et al. Among authors: monden n. Jpn J Clin Oncol. 1996 Dec;26(6):405-10. doi: 10.1093/oxfordjournals.jjco.a023256. Jpn J Clin Oncol. 1996. PMID: 9001344

4

Overexpression of metallothionein correlates with chemoresistance to cisplatin and prognosis in esophageal cancer.

Hishikawa Y, Abe S, Kinugasa S, Yoshimura H, Monden N, Igarashi M, Tachibana M, Nagasue N. Hishikawa Y, et al. Among authors: monden n. Oncology. 1997 Jul-Aug;54(4):342-7. doi: 10.1159/000227714. Oncology. 1997. PMID: 9216861

5

Surgically curable and incurable scirrhous carcinomas of the stomach.

Kinugasa S, Abe S, Tachibana M, Yoshimura H, Monden N, Dhar DK, Nagasue N, Harada Y, Nagaoka S. Kinugasa S, et al. Among authors: monden n. J Surg Oncol. 1997 Jul;65(3):194-200. doi: 10.1002/(sici)1096-9098(199707)65:3<194::aid-jso9>3.0.co;2-1. J Surg Oncol. 1997. PMID: 9236929

6

Prognostic significance of the expressions of metallothionein, glutathione-S-transferase-pi, and P-glycoprotein in curatively resected gastric cancer.

Monden N, Abe S, Sutoh I, Hishikawa Y, Kinugasa S, Nagasue N. Monden N, et al. Oncology. 1997 Sep-Oct;54(5):391-9. doi: 10.1159/000227725. Oncology. 1997. PMID: 9260601

7

Overexpression of transforming growth factor-beta1 in scirrhous carcinoma of the stomach correlates with decreased survival.

Kinugasa S, Abe S, Tachibana M, Hishikawa Y, Yoshimura H, Monden N, Dhar DK, Nagasue N, Nagaoka S. Kinugasa S, et al. Among authors: monden n. Oncology. 1998 Nov-Dec;55(6):582-7. doi: 10.1159/000011916. Oncology. 1998. PMID: 9778627

8

Prognostic factors and rational approach in the treatment of submucosal cancer of the stomach.

Kubota H, Tabara H, Kotoh T, Kumar DD, Monden N, Watanabe R, Kohno H, Nagasue N. Kubota H, et al. Among authors: monden n. J Surg Res. 1998 Dec;80(2):304-8. doi: 10.1006/jsre.1998.5423. J Surg Res. 1998. PMID: 9878329

9

nm23 in the primary and metastatic sites of gastric carcinoma. Relation to AFP-producing carcinoma.

Kumar Dhar D, Kubota H, Tabara H, Kotoh T, Monden N, Igarashi M, Kohno H, Nagasue N. Kumar Dhar D, et al. Among authors: monden n. Oncology. 1999;56(2):122-8. doi: 10.1159/000011952. Oncology. 1999. PMID: 9949298

10

[Pharmacokinetic study of intraperitoneally administered plachitin for non-curative gastrointestinal cancer].

Tabara H, Kinugasa S, Tachibana M, Abe S, Yoshimura H, Suzuki K, Monden N, Nakamura T. Tabara H, et al. Among authors: monden n. Gan To Kagaku Ryoho. 1995 Sep;22(11):1473-6. Gan To Kagaku Ryoho. 1995. PMID: 7574735 Clinical Trial. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page